Aspectos ultrassonográficos na síndrome dos ovários policísticos: novas recomendações / Sonographic aspects in polycystic ovary syndrome: new recommendations

Paula Cristina de Almeida Gomes

Abstract


Desde 1935, quando Stein-Leventhal correlacionaram achados cirúrgicos de ovários aumentados de volume com cápsula esbranquiçada e espessa à amenorreia, a síndrome dos ovários policísticos (SOP) vem sendo estudada. Sua fisiopatologia não está de todo elucidada, pois trata-se de disfunção endócrina, verdadeira metabolopatia e entidade multifatorial em seus elementos causais. Em 2004 houve consenso em Rotterdam, atualizado em 2012, para definir padrão diagnóstico; surgiram outros consensos mostrando a divergência e buscando uma maior abrangência, sempre enfatizando a anovulação, o hiperandrogenismo e as alterações ovarianas (Figura 1). Este material tem como objetivo mostrar as novas recomendações e limites do método.


Keywords


Ovários policísticos, Síndrome, Ultrassonografia.

References


Knochenhauer ES, Key TJ,Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab.1988;83(9):3078-82.

Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, et al. A survey of the polycystic ovay syndrome in the Greek island of Lesbos:hormonal and mrtabolic profile. J Clin Endocrinol Metab. 1998;84(11):4006-11.

Michelmore KF, Balen AH, Dunger DB, Vessey MP. Polycistic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol (Oxf) 1999;51(6):770-86

Assuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 2000;85(7):2434-8.

Azziz R, Woods KS, Reyna R, Key Tj, Knochenhauer ES, Yldiz BO,. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89(6):2745-9.

Melo AS, Vieira CS, Barbieri MA, Rosa-E-Silva AC, Cardoso VC, et al.High prevalence of polycystic ovary syndrome in women born small for gestational age. Hum Reprod. 2010;25(8):2124-31.

Fauser BC, Tarlatzis BC, Reba RW, Legro RS, Lobo R, et al. Consensus of women’s health aspects of polycistic ovary syndrome(PCOS): THE Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fert Steril.2012;97(1):28-38.e25.

Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Human Reprod. 2016;31(12):2841-55.

Stein IF,Leventhal ML.Amenorrhea associated with bilateral polycystic ovaries. A J Obst Gynecol 1935;29(2):181-91.

Sir-Petermann T, Maliqueo M, Codner E, Echiburú B, Crisosto N ,Perez V, et al. Early metabolic derangements in daughters of women with polycistic ovary syndrome. J Clin Endocrinol Metab.2007;92(12):4637-42.

Sir-Petermann T, Codner E, Perez V, Echiburú B, Maliqueo M, Ladrón de Guevara A et al. Metabolic and reprodutive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2009;94(6):1923-30.

Xita N, Tsatsoulis A. Review : fetal programming of polycistic ovary syndrome by androgen excesso:evidence from experimental, clinical, and genetic association studies.J Clin Endocrinol Metab.2006;91(5):1660-6.

Nestler JE. Metformin for the treatment of yhr polycystic ovary syndrome. N Engl J Med.2008;358(1):47-54.

Kazer RR, Kessel B, Yen SS. Circulating luteinizing hormone pulse frequency in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1987;65(2):233-6.

Dumesic DA, Oberfield SE, Stener Victorin E, Marshall JC, laven JS, Legro RS. Scientific Statement on the diagnostic Criteria, Epdemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endoc Rev. 2015; 36(5):487-525.

Frank S, Stark J, Hardy K. Follicle dynamics and anovulation in polycystic syndrome.Hum Reprod Update. 2008; 14(4):367-78.

Pastor CL, Griffin-Korf ML, Aloi JA, Evans WS, Marshall JC. Polycistic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocrinol Metab. 1998;83(2):58-90.

Daniels TL, Berga SL.Resistance of gonadotropin releasing hormone drive to sex steroid-induced suppression in hyperandrogebic anovulation. J Clin Endocrinol Metab. 1997;82(12):4179-83.

Hillier SG. Current concepts of the roles of follicle stimulating hormone in folliculogenesis. Hum Reprod. 1994;9(2):188-91.

Dunaif A, Segal KR. Futterweit W, Dobrjansky A. Profound peripheral insulin resistance , independ of obesity, in polycystic ovary syndrome. Diabetes.1989;38(9):1165-74.

Nestler JE. Insulin regulation of human ovarian androgens..Hum Reprod. 1997;12 Supp 1:52-62.

Diamanti-Kandarakis E, Argyrakapoulou G, Economou F, Kandaraki E, Koutisilieris M. Defects in insulin signaling pathways in ovarian steroidogenesis and other tissues in polycistic ovary syndrome (PCOS). J Steroid Biochem Mol Biol. 2008;109(3-5):242-6

Nestker JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, et al. A direct effect of hyperinsulinemia on serum sex hormone-binding globuline levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab. 1991;72(1):83-9.

Legro RS, Driscoll D, Strauss JF 3rd, Fox J, Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA 1998;95(25):14956-60.

Crosignani PG, Nicolosi AE. Polycistic ovarian disease: heritability and heterogeneity. Human Reprod Update. 2001;7(1):3-7.

Legro RS, Strauss JF 3rd. Molecular progress in infertility:polycystic ovary syndrome. Fert Steril. 2002;78(3):569-76;

Li L, Baek KH. Molecular genetics of polycystic ovary syndrome:un update.Curr Mol Med. 2015;15(4):331-42.

Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004, 19(1):41-7.

Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L,Norman RJ;international PCOS Network. Recommendations from the international evidence –based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018 Jul 19.

Rosenfeld RL.Diagnostic evaluation of polycystic ovary syndrome in adolescents. Uptodated Mar 28m2019

Barbieri RL, et al. Diagnosis of polycystic ovary syndrome in adults.Uptodated Apr 2019.

SÉRIE ORIENTAÇÕES E RECOMENDAÇÕES FEBRASGO, Síndrome dos Ovários Policísticos, 2018.




DOI: https://doi.org/10.34119/bjhrv4n2-202

Refbacks

  • There are currently no refbacks.